Presence of precore and core promoter mutants limits the probability of response to peginterferon in hepatitis B e antigen‐positive chronic hepatitis B

Publisher： John Wiley & Sons Inc

E-ISSN： 1527-3350|56|1|67-75

ISSN： 0270-9139

Source： HEPATOLOGY, Vol.56, Iss.1, 2012-07, pp. : 67-75

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Precore/Core promoter variants to predict significant fibrosis in both HBeAg positive and negative chronic hepatitis B

By  

LIVER INTERNATIONAL (ELECTRONIC), Vol. 35, Iss. 9, 2015-09 ,pp. : 2082-2089

John Wiley & Sons Inc

Access to resources Recommend Favorite

Optimization of lamivudine therapy

By  

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, Vol. 30, Iss. 4, 2015-04 ,pp. : 748-755

John Wiley & Sons Inc

Access to resources Recommend Favorite

Adding pegylated interferon to entecavir for hepatitis B e antigen–positive chronic hepatitis B: A multicenter randomized trial (ARES study)

By  

HEPATOLOGY, Vol. 61, Iss. 5, 2015-05 ,pp. : 1512-1522

John Wiley & Sons Inc

Access to resources Recommend Favorite

Effect of hepatitis B virus subgenotype on antiviral response in nucleoside‐treated hepatitis B envelope antigen‐positive patients

By  

HEPATOLOGY RESEARCH, Vol. 48, Iss. 2, 2018-02 ,pp. : 134-143

John Wiley & Sons Inc

Access to resources Recommend Favorite

Sequential Accumulation of the Basal Core Promoter and the Precore Mutations in the Progression of Hepatitis B Virus-Related Chronic Liver Disease

By  

Intervirology, Vol. 49, Iss. 5, 2006-08 ,pp. : 266-273

Karger

Access to resources Recommend Favorite